Skip to main content

Advances in Clinical Chemistry

  • 1st Edition, Volume 131 - February 20, 2026
  • Latest edition
  • Editor: Gregory S. Makowski
  • Language: English

Advances in Clinical Chemistry, Volume 131 in this ongoing series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics… Read more

World Book Day celebration

Where learning shapes lives

Up to 25% off trusted resources that support research, study, and discovery.

Description

Advances in Clinical Chemistry, Volume 131 in this ongoing series, highlights new advances in the field, with this new volume presenting interesting chapters on a variety of topics, including Advances in Volatile Organic Compound Biomarker Detection, 2D-DIGE proteomics, Interacting partners of Tau protein in Alzheimer’s disease, Biosensors for Detection of Autoimmune Disease, Small Molecule Biomarkers in Infectious Disease, and Diagnosis and Risk Factors in Pancreatogenic Diabetes. Each chapter is written by an international board of authors.

Key features

  • Provides the latest information on Clinical Chemistry
  • Offers outstanding and original reviews on a range of Clinical Chemistry research topics
  • Serves as an indispensable reference for researchers and students alike

Readership

Students, clinicians, academicians

Table of contents

1. Advances in Volatile Organic Compound Biomarker Detection
Mangilal Agarwal

2. 2D-DIGE proteomics
Paul Dowling

3. Interacting partners of Tau protein in Alzheimer’s disease
Subashchandrabose Chinnathambi

4. Biosensors for Detection of Autoimmune Disease
Evangelia Livaniou

5. Small Molecule Biomarkers in Infectious Disease
Laura-Isobel McCall

6. Diagnosis and Risk Factors in Pancreatogenic Diabetes
Ravi Kumar Sharma

Product details

  • Edition: 1
  • Latest edition
  • Volume: 131
  • Published: February 25, 2026
  • Language: English

About the editor

GM

Gregory S. Makowski

Dr Gregory S Makowski is a board-certified clinical chemist and fellow of the National Academy of Clinical Biochemistry. Following receipt of his PhD in Biochemistry from the University of Connecticut Storrs, he pursued post-doctoral studies at the University of Connecticut School of Medicine in Farmington that culminated in joint appointments in the School of Medicine and the Department of Laboratory Medicine at John Dempsey Hospital. He has numerous clinical and basic science publications and serves on various scientific and editorial boards. He is actively engaged in the training of Pathology residents and fellows in the Department of Pathology and Laboratory Medicine at Hartford Hospital. He currently serves as Vice President Clinical Laboratory Services Hartford HealthCare in Connecticut.

Affiliations and expertise
Vice President and Chief Scientific Officer, Clinical Laboratory Partners, Newington, CT, USA

View book on ScienceDirect

Read Advances in Clinical Chemistry on ScienceDirect